Background
Immunoglobulin (Ig) G4-related disease, previously referred to as IgG4-related sclerosing disease or hyper-IgG4 disease, may occur in the lung, involving alveolar parenchyma, airways, mediastinum, and pleura. Various pulmonary manifestations of IgG4-related disease have been reported but a cavitating lung disease has not been documented in this setting. Herein, we describe a 60-year-old man who presented with hemoptysis and cavitating lung disease with clinical, laboratory, and histopathologic findings compatible with IgG4-related disease. To the best of our knowledge, this is the first reported case of IgG4-related disease manifesting as a cavitating lung lesion.
Case Report
A 60-year-old white male presented for a second opinion regarding a 2-year history of cough and streaky hemoptysis. He was an active smoker with history of smoking for 40 packyears. Before presenting to our center, he had undergone a diagnostic evaluation elsewhere that included a chest CT (which revealed a thick-walled cavitating lesion in the left upper lobe) and a bronchoscopy with nondiagnostic transbronchial biopsy results. He was treated with a course of broad-spectrum antibiotics with no improvement, followed by a thoracotomy with resection of the cavitary lesion. The biopsy specimen apparently revealed an inflammatory lesion with no evidence of malignancy. Review of all microbial cultures, including mycobacterial culture of the lung tissue, was negative.
His cough was associated with whitish phlegm, and had minimal nocturnal symptoms. He never had a frank hemoptysis, and noted blood-streaked sputum on many occasions. He complained of shortness of breath, which was grade 1 on the mMRC scale. He denied night sweats, weight loss, or loss of appetite. His medical history was significant for COPD, dyslipidemia, reflux esophagitis, and obstructive sleep apnea. His cough and hemoptysis continued even after complete resection of the cavitary lesion.
On examination, he was afebrile with a SpO2 of 97% on room air at rest. Bilateral nontender parotid gland enlargement was noted. The rest of the physical exam and review of systems was without abnormality. Laboratory studies revealed anemia Although the presence of neutrophilic aggregates has been noted in pulmonary IgG4-related lung disease (IgG4-RLD), a cavitary lesion has not been documented as a feature of IgG4-RLD. We believe that this case could be a possible cavitary IgG4-RLD in light of his other manifestations, including the parotid gland enlargement elevated serum IgG4 level, and the lack of any viable alternative diagnoses. While the histopathologic diagnosis was challenging due to the presence of cavitary lesion, the remaining histopathologic findings with increased IgG4+ plasma cells were acceptable for IgG4-RLD. There was no evidence of extrapulmonary IgG4-related disease other than parotid gland enlargement. Treatment was initiated with oral prednisone 60 mg/day, and subsequently mycophenolate mofetil (MMF) was added with slow tapering of prednisone over the following 2 months. Follow-up 1 year later while on 2 gm/day of MMF and a tapering dose of prednisone at 5 mg per day showed stable pulmonary function. 
Discussion
IgG4 accounts for only 4-6% of the total serum IgG in normal subjects, and is the least abundant of the IgG subclasses [1] . Serum IgG4 level can be elevated in a number of allergic and auto-immune disorders like autoimmune pancreatitis, primary sclerosing cholangitis, ANCA vasculitis, rheumatoid arthritis, inflammatory bowel disease, cutaneous plasmacytosis, and autoimmune atrophic gastritis [2, 3, 4] .
IgG4-RD is a systemic fibro-inflammatory disease associated with IgG4-positive plasma cell infiltration and elevated circulating levels of IgG4 [5, 6] . Virtually any organ system can be involved in IgG4-RD [7] . The 3 major histopathological features associated with IgG4-RD are dense lymphoplasmacytic infiltrate, storiform fibrosis, and obliterative phlebitis [8] . However, the last 2 features are often absent in some sites, including lung [8] , lymph nodes [9] , minor salivary glands, and lacrimal glands [10] . Intrathoracic manifestations of IgG4-RD include parenchymal nodules or masses, interstitial lung disease, tracheobronchial stenosis, pleural nodules, pleural effusion, mediastinal lymphadenopathy, and fibrosing mediastinitis [11] . However, cavitary lung disease has not been previously reported in IgG4-RD.
The consensus statement requires an elevated number of IgG4-positive plasma cells within tissues along with characteristic histopathologic features for diagnosis [12] . In surgical lung biopsy specimens, >50 IgG4-positive plasma cells per high-power field and the IgG4+/IgG+ plasma cell ratio of >40% is reportedly highly specific [13, 14] .
There are no randomized treatment trials for IgG4-RD, and treatment decisions are based on data from retrospective studies. Although most patients respond favorably to glucocorticoids [15] , the dosing and duration of treatment are largely undefined. A minority of patients are steroid-resistant. Azathioprine, MMF, and rituximab have been reported to be effective in these cases, as well as those requiring prolonged therapy [16, 17] .
Conclusions
We present a case of cavitating lung disease as a possible manifestation of IgG4-RD that has not been reported previously. Our patient had an excellent response to immunosuppression, with complete resolution of all lesions. An increased awareness of IgG4-RD and its myriad pulmonary manifestations is very important for the pulmonologist. 
